Authors
Latest:
Treatment Decisions and its Relation to Patient AccessibilityFinal thoughts from expert KOLs regarding treatment decisions and how they relate to patient accessibility when manage dyslipidemia.
Latest:
Emerging Treatments of Anhedonia in Patients with Major Depressive DisorderDr Andrew Cutler and Dr Greg Mattingly comment about emerging treatments to treat anhedonia and highlight lifestyle modifications that support the wellbeing of patients with Major Depressive Disorder.
Latest:
Ketamine for the Treatment of MDDRyan Oakley, MD, takes a closer look at the recent history of ketamine in depression. He also explores the differences between ketamine and esketamine.
Latest:
Helping Your Patients Avoid the Migraine Trigger TrapForget what you think you know about red wine or chocolate ‘activating’ migraine. Many commonly accepted “triggers” aren’t triggers at all.
Latest:
Bariatric Surgery is Associated with Reduced Risk of Pancreatic Cancer: Analysis of a US National DatabaseA history of bariatric surgery was associated with up to 50% reduced risk of PDAC among a national cohort.
Latest:
Final Thoughts on the Opioid Crisis and Normalizing NaloxoneThe multidisciplinary panel of experts share final thoughts on strategies to normalize naloxone and decrease barriers to its obtainment and utilization.
Latest:
Reducing the Stigma of Unplanned Pregnancy Starts with a ConversationAn unplanned pregnancy can translate into a multitude of health factors and risks for both the mother and the baby.
Latest:
Quantifying the Association Between Anxiety and Depressive Features and High Disease Activity Scores in SLEAnxiety and depression can limit engagement with healthcare or treatment leading to later diagnosis, poor treatment adherence, and poor disease control with associated negative sequelae.
Latest:
The Burden of Treatment Resistant DepressionRyan J. Wakim, MD, DFAPA, explores the causes and diagnostic criteria for treatment resistant depression. He also discusses the importance of comprehensive assessment and personalized approaches to care.
Latest:
Helpful Hints for Use of Biosimilars in Ophthalmology PracticesDr Peter Kaiser shares helpful hints for patient communication and for including biosimilars in clinical practice.
Latest:
Final Thoughts: Awareness and Communication in DiabetesThought leaders in diabetes provide closing remarks about the importance of continuous awareness of glycemic control in patients as well as the need for effective communication between patients and providers.
Latest:
Addressing Current Treatment Gaps in Pediatric and Adult IBDCurrent treatment limitations in inflammatory bowel disease and the rationale for earlier initiation and use of newer therapies to manage pediatric and adult patients.
Latest:
Community Provider Engagement in HCVMamta Jain, MD, MPH, summarizes community outreach efforts regarding the training and education of health workers.
Latest:
Emerging Treatments Over the Horizon for IBDJessica Allegretti, MD, MPH, and Edward Loftus Jr., MD, review emerging agents in the later phases for the management of IBD.
Latest:
Don't Miss a Beat: EMPACT-MI at ACC.24, with Javed Butler, MDIn this ACC.24 episode of Don't Miss a Beat, hosts are joined by Javed Butler, MD, for a breakdown of the EMPACT-MI trial.
Latest:
Building Confidence in Biosimilars in OphthalmologyRishi P. Singh, MD; and Michael A. Klufas, MD, discuss how to gain both physician and patient trust when it comes to using biosimilars to treat ophthalmologic conditions.
Latest:
Rheumatoid Arthritis Quiz: TNF InhibitorsHow well do patients with rheumatoid arthritis adhere to treatment with a TNF inhibitor and how likely and long lasting is remission? Test your knowledge with this quiz.
Latest:
Looking Into the Future of Lipid ManagementDr Taub, Dr Patel, and Dr Kohli look ahead to the future of the management of cardiovascular risk and hyperlipidemia
Latest:
Clinical Pearls for the Management of ALGSExperts in pediatric hepatology share advice for the optimal management of Alagille syndrome.
Latest:
Case 3: 57-Year-Old Man With PsAAna-Maria Orbai, MD, MHS, leads the discussion on a real-world case scenario of a 57-year-old man who presents with severe plaque psoriasis and arthritis and shares clinical impressions as well as therapeutic goals for the patient.
Latest:
Impact of the Expanding Treatment Landscape on the Treatment Algorithm of Plaque PsoriasisTJ Chao and Kristine Kucera, PA’s discuss the changing treatment algorithms of plaque psoriasis with the arrival of novel agents such as the TYK2 inhibitors.
Latest:
Blood Pressure Monitoring and Substance Use Considerations With EsketamineGeoffrey Grammer, MD, offers guidance on navigating challenges such as elevated blood pressure and substance misuse and abuse regarding the use of esketamine.
Latest:
Key Takeaways and Prospective Treatment AdvancesDavid Hudesman, MD, Maia Kayal, MD, Miguel Regueiro, MD, Anita Afzali, MD, and Millie Long summarize their discussion of Inflammatory Bowel Disease (IBD) and discuss prospective advances in treatment options.
